Home> HARMONY is part of the IMI 'Big Data for Better Outcomes' program.

HARMONY is part of the IMI 'Big Data for Better Outcomes' program.

 

The Big Data For Better Outcomes Programme (BD4BO) is an umbrella programme of the Innovative Medicines Initiative 2 (IMI2). IMI2 is a collaboration between the European Union and European Federation of Pharmaceutical Industries and Associations (EFPIA) and is the world’s largest public-private partnership (PPP) in the life sciences. EFPIA companies and associated partners do not receive any EU funding, but contribute to the projects “in kind”, for example by contributing their researchers’ time or providing access to research facilities or resources.

The aim of the Big Data For Better Outcomes Programme (BD4BO) is to improve health outcomes and healthcare systems in Europe by maximizing the potential of Big Data.

Fundamentally, Big Data has the potential to have a transformative effect across a board spectrum of areas including healthcare systems, patient stratification and disease treatment, trial and product design, and most importantly, patient use of medicines. However, the potential of Big Data will only be unlocked when healthcare systems move beyond the mere collection of large amounts of data. To achieve its potential previously separated data sets must be linked and analyzed using suitable Big Data analytics. This approach will offer all stakeholders novel ways to accelerate research and to identify the right treatment for individual patients (personalized medicine). Access to large combined data sets that present a more comprehensive picture of patients allows patient-reported outcomes to be measured more accurately. If they are of high enough quality and/or supported by other findings such as clinical trial data they can support decision-makers in shaping patient focused healthcare systems.

BD4BO contains the following projects:

Link to the BD4BO website >